Metisox provides AI-driven translational safety intelligence for pharmaceutical and biotechnology R&D teams.

Our mission is to enable safer, smarter drug discovery by combining expert biological curation with multi-omics analytics.

🔹 What we do:

• Target Safety Assessments (TSA) – expert-curated evaluations of novel drug targets, integrating mechanistic, genetic, and pathway data to identify on- and off-target risks.

• Carcinogenicity Risk Assessments (CRA) – fully aligned with ICH S1B(R1) Weight-of-Evidence guidelines, helping oncology and safety teams modernize their preclinical strategy.

•Proprietary technology platform for target safety / drug discovery – our proprietary multi-omics knowledgebase linking millions of curated biological, toxicological, and pathway relationships across species.

• Custom bioinformatics & biomarker discovery – transforming complex data into actionable insights for translational safety and R&D.

⚛️ By uniting AI, systems biology, and expert toxicology, Metisox supports decision-making from target selection to IND — helping our partners reduce attrition and accelerate the development of safe, effective therapeutics.

🌐 www.metisox.com

📩 info@metisox.com

Biotechnology

Health Care

Metisox

Org chart

Teams

Offices

Metisox

Org chart

Teams

Offices

Related companies